Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.91954 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.30571 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.22924 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.5275 | 85 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.33836 | 85 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.05228 | 84 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.73821 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.27843 | 85 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.21894 | 84 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.29317 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.97637 | 82 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.57826 | 86 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.34782 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.28609 | 85 |